People over the age of 14 should consume more than 2.4 micrograms (mcg) of vitamin B-12 daily
Gastrointestinal dysfunction in Parkinson's disease
Injection site reactions The most frequently reported side effect involves the injection site itself
Asea went on to perform postdoctoral training at the University of Miami School of Medicine in Miami, USA and the Schepens Eye Research Institute, Harvard Medical School and the Brigham & Womens Hospital, Harvard Medical School, Boston USA Asea established his first independent research lab at the Dana-Farber Cancer Institute, Harvard Medical School in Boston, USA Asea was recruited as the Deputy Director for the Center for Molecular Stress Response at Boston University School of Medicine and the Boston Medical Center, Boston, USA Asea was recruited to be the Executive Director and Chief, Division of Investigative Pathology at the Baylor Scott & White Hospital and the Texas A&M Health Science Center College of Medicine, Temple, USA Asea went on to be recruited as Professor and Chairman of the Department of Microbiology, Biochemistry & Immunology at to Morehouse School of Medicine, Atlanta, USA Vice President for Research and Professor and Chairman of the Department of Neurosciences at the University of Dammam in Dammam, Saudi Arabia Professor and Head, Section of Translational Medicine, Department of Cutting-Edge Medicine and Neurosciences at the University of Palermo, Italy Professor of Medicine and Executive Director Precision Therapeutics Proteogenomics Diagnostics Center at the University of Toledo College of Medicine, Toledo, USA President & CEO, NampEVA BioTherapeutics, Dover USA a clinical stage biopharmaceutical company dedicated to delivering affordable medicines to people in LMIC and to reinvest locally to promote medical, science and technology education
This month, two new studies help close the loop: Study #1 (Lancet eBioMedicine, July 2025): Longitudinal plasma proteomics in ~100 humans before and after metformin revealed 23 consistently altered proteins
For example, the HR for treatment discontinuation was 0.65 (95% CI 0.61, 0.68) for obesity class II/III vs normal weight (Table 2)
